We are a commercial biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers.
CTI BioPharma Corp. 3101 Western Avenue Suite 800 Seattle, WA 98121
